This is a demo store. No orders will be fulfilled.
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
24 Dec 2015  |  North America  |  Market Research
Global Clinical Next-generation Sequencing Market
Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement
This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tab...
$1,500.00 -
11 Dec 2015  |  South Asia, Middle East & North Africa  |  Market Research
Impact of Lifting Nuclear Sanctions on Iran’s Healthcare Market—Now and Later
The Lifting of Nuclear Sanctions on Iran will open a Plethora of Opportunities in the Medical Tourism and Pharmaceutical Sectors
Several international sanctions were imposed over Iran over the last decade, restraining its international trade capacity. Yet, Iran is the 17th largest economy in the world; its Gross Domestic Product (GDP) was $415.3 billion in 2014. The nuclear sanctions imposed by the United Nations on Iran resulted in trade bans and restrictions on financial t...
$1,500.00 -
26 Oct 2015  |  Asia Pacific  |  Market Research
Asia-Pacific Regulations Driving Innovation in Healthcare
Innovative Public-Private Initiatives Attracting Investment in Research & Development
The following article is an abstract of some recent whitepapers developed by Frost & Sullivan on the evolving regulatory policies impacting healthcare in Asia-Pacific (APAC). Government initiatives and incentives in the APAC have resulted in increasing investment in research and development (R&D) in healthcare, while free trade economics across the...
$1,500.00 -
30 Sep 2015  |  Europe  |  Market Research
Profiling the Top Mergers and Acquisition Within Medical Devices Space
Changing Healthcare Dynamics Driving the M&A
The landscape of healthcare is rapidly changing worldwide as governments are reducing healthcare spending through means such as reimbursement cuts. The medical devices market bears the direct brunt of these measures. To overcome this, medical device companies are involved in active mergers and acquisitions (M&A). The study analyses the key factors ...
$1,500.00 -
15 Sep 2015  |  North America  |  Market Research
Development of Value-based Imaging
Driving Vendor-Customer Relationships in a Value-focused Medical Imaging Environment in the United States
A trickle-down effect from healthcare reform, together with a transformation operated from within, is pushing the medical imaging industry into a value-focused environment. Although it does seem that the volume-to-value transition in medical imaging will be more of a gradual process than an overnight change, it is already well underway. Its impact ...
$2,450.00 -
03 Sep 2015  |  Asia Pacific  |  Market Research
Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020
Policies Raising Standards and Lowering Barriers Across ASEAN
The research service provides an analysis of the policies impacting the healthcare market in the Association of Southeast Asian Nations (ASEAN). It includes the current trends, market size, revenue forecast, and market drivers and restraints. Healthcare market participants and key opinion leaders were interviewed to obtain their perception about tr...
$2,450.00 -
02 Sep 2015  |  Global  |  Market Research
The New Age of Regenerative Medicine
Why Stem Cell Therapy?
Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases suc...
$1,500.00 -
19 Aug 2015  |  North America  |  Market Research
Top 6 Trends Affecting the Diagnostics Market
Evolving Strategies by Market Leaders to Keep Up With Changing Healthcare Trends
The IVD market constantly changing. Mega Trends such as consolidation, automation, and reimbursement policies affect every aspect of the market. This study looks at the effects of these trends on three global consumer segments: hospitals, laboratories, and patients. The growing importance of diagnostics in patient care is expanding beyond hospitals...
$1,500.00 -
14 Aug 2015  |  North America  |  Market Research
The Australian Contract Research Organization Market
Early Phase Clinical Trials are Set to Drive the Australian CRO Market
Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...
$1,500.00 -
12 Aug 2015  |  Global  |  Market Research
Singapore Contract Research Organization Market
Singapore will Remain in the Global Spotlight as the Strategic Hub of the CRO Market in APAC.
The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiolo...
$1,500.00